Strength
400; 100; 100 mg/1; mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958240101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/19/2024
Active Ingredients
SOFOSBUVIR; VELPATASVIR; VOXILAPREVIRApproval Type
New Drug (NDA)
FDA Application
NDA209195On Market Since
7/18/2017
Pharmacological Classes
Breast Cancer Resistance Protein Inhibitors
Breast Cancer Resistance Protein Inhibitors
HCV NS3/4A Protease Inhibitors
Hepatitis C Virus NS3/4A Protease Inhibitor
Hepatitis C Virus NS5A Inhibitor
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Organic Anion Transporting Polypeptide 1B1 Inhibitors
Organic Anion Transporting Polypeptide 1B1 Inhibitors
Organic Anion Transporting Polypeptide 1B3 Inhibitors
Organic Anion Transporting Polypeptide 1B3 Inhibitors
Organic Anion Transporting Polypeptide 2B1 Inhibitors
P-Glycoprotein Inhibitors
P-Glycoprotein Inhibitors
RNA Replicase Inhibitors
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
MYRBETRIQ ER 8 MG/ML SUSP
Brand
00469502099•Astellas Pharma US, Inc.
$2.2097
per ML
ZONISADE 100 MG/5 ML ORAL SUSP
Brand
52652800101•Azurity Pharmaceuticals Inc.
$2.7530
per ML
NEORAL 25 MG GELATIN CAPSULE
Brand
00078024615•Novartis Pharmaceuticals Corporation
$2.8879
per EA
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
SANDIMMUNE 25 MG CAPSULE
Brand
00078024015•Novartis Pharmaceuticals Corporation
$4.3773
per EA
BRILINTA 90 MG TABLET
Brand
00186077739•AstraZeneca Pharmaceuticals LP
$7.4222
per EA
BRILINTA 90 MG TABLET
Brand
00186077760•AstraZeneca Pharmaceuticals LP
$7.4222
per EA
BRILINTA 60 MG TABLET
Brand
00186077660•AstraZeneca Pharmaceuticals LP
$7.4281
per EA
KALETRA 200-50 MG TABLET
Brand
00074401412•AbbVie Inc.
$8.3041
per EA
KALETRA 200-50 MG TABLET
Brand
00074679922•AbbVie Inc.
$8.3041
per EA